These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 20031109)
1. The impact of ethnicity on metabolic outcomes during treatment with antipsychotics: complexities abound. Citrome L; Krakowski M J Clin Psychiatry; 2009 Nov; 70(11):1608-9. PubMed ID: 20031109 [No Abstract] [Full Text] [Related]
2. Metabolic syndrome in inpatients treated with clozapine. Suzuki T J Clin Psychiatry; 2011 Jun; 72(6):872-3; author reply 873-4. PubMed ID: 21733485 [No Abstract] [Full Text] [Related]
3. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study. Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584 [TBL] [Abstract][Full Text] [Related]
4. Delusion of pregnancy associated with antipsychotic induced metabolic syndrome. Manjunatha N; Saddichha S World J Biol Psychiatry; 2009; 10(4 Pt 2):669-70. PubMed ID: 19096992 [TBL] [Abstract][Full Text] [Related]
5. Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Correll CU; Frederickson AM; Kane JM; Manu P Schizophr Res; 2007 Jan; 89(1-3):91-100. PubMed ID: 17070017 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics and antipsychotic drugs. Sher L Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071218 [No Abstract] [Full Text] [Related]
7. Benign ethnic neutropenia and clozapine monitoring. Blackman G J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):967-8. PubMed ID: 18645423 [No Abstract] [Full Text] [Related]
8. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia. Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566 [TBL] [Abstract][Full Text] [Related]
9. [Metabolic syndrome in patients with schizophrenia and antipsychotic treatment]. Aguilar E; Coronas R; Caixàs A Med Clin (Barc); 2012 Nov; 139(12):542-6. PubMed ID: 22841467 [TBL] [Abstract][Full Text] [Related]
10. Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context. Malhi G; Adams D; Plain J; Coulston C; Herman M; Walter G Australas Psychiatry; 2010 Feb; 18(1):32-41. PubMed ID: 20039791 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome with the atypical antipsychotics. Pramyothin P; Khaodhiar L Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):460-6. PubMed ID: 20717020 [TBL] [Abstract][Full Text] [Related]
13. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics. Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia. Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493 [TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study. Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update. Sriretnakumar V; Huang E; Müller DJ Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648 [TBL] [Abstract][Full Text] [Related]